Literature DB >> 19634716

Identification of Mycobacterium tuberculosis-specific genomic regions encoding antigens inducing protective cellular immune responses.

Abu Salim Mustafa1, Rajaa Al-Attiyah.   

Abstract

Comparative genomic studies have identified 11 regions of difference (RD1, RD4, RD5, RD6, RD7, RD9, RD10, RD11, RD12, RD13 and RD15) in Mycobacterium tuberculosis genome which are absent in all vaccine strains ofM. bovis BCG. The proteins encoded by genes predicted in these RDs could be useful as protective vaccines and/or exacerbate the disease process by inducing cellular immune responses involved in protection and pathogenesis of tuberculosis. In our studies, by using pools of overlapping synthetic peptides covering the sequence of putative proteins encoded by genes predicted in each RD, we have determined the cellular immune responses in relation to antigen-induced proliferation and secretion of the protective Th1cytokine IFN-gamma and the pathologic Th2 cytokine IL-10 by peripheral blood mononuclear cells of tuberculosis patients and healthy humans. It has been observed that peptides of RD1pool induced the highest antigen-induced proliferation and IFN-gamma responses, whereas the peptides of RD12pool and RD13pool induced the highest IL-10 responses. Furthermore, addition of RD12pool and RD13pool to peripheral blood mononuclear cells (PBMCs) cultures inhibited the RD1pool-induced secretion of IFN-gamma by PBMCs of healthy humans. These results suggest the relevance of RD1-encoded proteins in protection and RD12- and RD13-encoded proteins in pathogenesis of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634716

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  6 in total

Review 1.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

2.  Cellular immune responses to recombinant Mycobacterium bovis BCG constructs expressing major antigens of region of difference 1 of Mycobacterium tuberculosis.

Authors:  Kholoud Shaban; Hanady A Amoudy; Abu S Mustafa
Journal:  Clin Vaccine Immunol       Date:  2013-06-12

3.  Identification of RD5-encoded Mycobacterium tuberculosis proteins as B-cell antigens used for serodiagnosis of tuberculosis.

Authors:  Miao-Miao Zhang; Jun-Wei Zhao; Zhan-Qiang Sun; Jun Liu; Xiao-Kui Guo; Wen-Di Liu; Shu-Lin Zhang
Journal:  Clin Dev Immunol       Date:  2012-06-04

4.  Factors associated with tuberculosis among patients attending a treatment centre in Zaria, North-west Nigeria, 2010.

Authors:  Ndadilnasiya Endie Waziri; Simeon Cadmus; Patrick Nguku; Olufunmilayo Fawole; Olajide Adewale Owolodun; Hyelshilni Waziri; Luka Ibrahim; Oladayo Biya; Saheed Gidado; Samuel Badung; Peterside Kumbish; Peter Nsubuga
Journal:  Pan Afr Med J       Date:  2014-07-21

Review 5.  In silico analysis and experimental validation of Mycobacterium tuberculosis -specific proteins and peptides of Mycobacterium tuberculosis for immunological diagnosis and vaccine development.

Authors:  Abu Salim Mustafa
Journal:  Med Princ Pract       Date:  2013-08-31       Impact factor: 1.927

Review 6.  Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins.

Authors:  Abu Salim Mustafa
Journal:  Vaccines (Basel)       Date:  2021-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.